A dental prosthesis and a process for design and manufacturing, incorporating a dental implant framework and veneering overlay that will be designed and manufactured simultaneously and permanently fixated to one another.

[Problem] To select a dental cement or a trial test material for easily obtaining high color tone adaptability to peripheral tooth substances, in mounting of or trial test of a prosthesis device [Solution] To provide a dental cement set consisting of a plurality of dental cements having color tones including color tones of 3 to n colors for selecting and using a dental cement from the plurality of dental cements having the color tones including the color tones of the 3 to n colors after trial test with trial test materials for the dental cement to be used from the plurality of dental cements having the color tones including the color tones of the 3 to n colors, wherein: the amount of information loss Pin with regard to first principal component determined by principal component analysis is less than 2, and. the dental cement set satisfies following Formula 1.
2≤((CL*.sub.p−1−CL*.sub.p).sup.2+(Ca*.sub.p−1−Ca*.sub.p).sup.2+(Cb*.sub.p−1−Cb*.sub.p).sup.2).sup.1/2<8  Formula 1
(wherein p is an arbitrary integer of 2≤p≤n).

[Problem] To select a dental cement or a trial test material for easily obtaining high color tone adaptability to peripheral tooth substances, in mounting of or trial test of a prosthesis device [Solution] To provide a dental cement set consisting of a plurality of dental cements having color tones including color tones of 3 to n colors for selecting and using a dental cement from the plurality of dental cements having the color tones including the color tones of the 3 to n colors after trial test with trial test materials for the dental cement to be used from the plurality of dental cements having the color tones including the color tones of the 3 to n colors, wherein: the amount of information loss Pin with regard to first principal component determined by principal component analysis is less than 2, and. the dental cement set satisfies following Formula 1.
2≤((CL*.sub.p−1−CL*.sub.p).sup.2+(Ca*.sub.p−1−Ca*.sub.p).sup.2+(Cb*.sub.p−1−Cb*.sub.p).sup.2).sup.1/2<8  Formula 1
(wherein p is an arbitrary integer of 2≤p≤n).

In a functionalization method for use in dentistry, and a method for same, the application device includes a support for receiving a partially processed shaped dental part for producing a dental restoration, and a dispensing device for the at least partial infiltration of a functionalization material onto the surface of the shaped dental part.

In a functionalization method for use in dentistry, and a method for same, the application device includes a support for receiving a partially processed shaped dental part for producing a dental restoration, and a dispensing device for the at least partial infiltration of a functionalization material onto the surface of the shaped dental part.

A biocompatible composite material for controlled release is disclosed, comprising a biocompatible metal oxide structure with a loaded network of pores. The pore network of the biocompatible composite material is filled with a uniformly distributed biologically active micellizing amphiphilic molecule, the size of these pores ranging from about 0.5 to about 100 nanometers. The material is characterized in that when exposed to phosphate-buffered saline (PBS), the controlled release of the active amphiphilic molecule is predominantly diffusion-driven over time.

A biocompatible composite material for controlled release is disclosed, comprising a biocompatible metal oxide structure with a loaded network of pores. The pore network of the biocompatible composite material is filled with a uniformly distributed biologically active micellizing amphiphilic molecule, the size of these pores ranging from about 0.5 to about 100 nanometers. The material is characterized in that when exposed to phosphate-buffered saline (PBS), the controlled release of the active amphiphilic molecule is predominantly diffusion-driven over time.

A dental composition comprising: a) about 1 to about 80% by weight of particulate material including: (i) calcium silicate, calcium aluminate, tetracalcium aluminoferrite, calcium phosphate, calcium sulfate, silica, alumina, calcium oxide, calcium hydroxide, or mixtures thereof; and b) about 1 to about 50% by weight liquid carrier including: (i) water-soluble polymer, (ii) surfactant, the surfactant is selected from the group consisting of alkyl sulfates, alkyl ether sulfates, and sarcosinates, and mixtures thereof; and (iii) water; wherein the particulate and liquid carrier being mixed together to form a hydrate gel material that can harden.

The present invention relates to pharmaceutical compositions and methods for the treatment of peri-implant diseases, in particular peri-implant disease characterized by the destruction of the crest of the alveolar bone supporting the implant. Specifically, the method comprising the step of applying to a peri-implant bone displaying crestal resorption a 5 pharmaceutical composition comprising biocompatible bone augmentation material coated with a matrix composition which provides local controlled and pro longed release of at least one pharmaceutically active agent at the bone loss site.

The present invention provides a zirconia pre-sintered body that can be fired into a sintered body having translucency and strength suited for dental use (particularly, at the dental clinic), even with a short firing time. The present invention relates to a zirconia pre-sintered body comprising: zirconia; and a stabilizer capable of inhibiting a phase transformation of zirconia, wherein the zirconia predominantly comprises a monoclinic crystal system, and the zirconia pre-sintered body comprises a plurality of layers that differ from each other in the content of the stabilizer relative to the total mole of the zirconia and the stabilizer.